Mcf Advisors LLC Myriad Genetics Inc Transaction History

Mcf Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $24,395 - $32,988	-1,011 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$10.69 - $16.49 $40,354 - $62,249	-3,775 Reduced 78.88%	1,011 $11,000
Q3 2019 Oct 22, 2019	BUY	$22.08 - $47.08 $83,352 - $177,727	3,775 Added 373.39%	4,786 $137,000
Q4 2018 Jan 25, 2019	SELL	$27.23 - $45.56 $136,150 - $227,800	-5,000 Reduced 83.18%	1,011 $29,000
Q3 2018 Oct 24, 2018	BUY	$37.57 - $50.34 $225,833 - $302,593	6,011 New	6,011 $277,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.